|
Targeting alpha particle-emitting radionuclides to the nuclei of cancer cells
|
1R41CA126072-01A2
|
$115,953
|
$115,953
|
QUINN, THOMAS
|
ALPHAMED, INC
|
|
Processing Ac-227 sources for lead-212 and radium-223 required by cancer research
|
1R41CA124302-01A1
|
$111,300
|
$22,260
|
Soderquist, Chuck
|
ALPHAMED, INC
|
|
Transgenic Plant Technology for Producing Therapeutic Recombinant Antibodies
|
5R44CA117211-03
|
$706,899
|
$176,725
|
WONG, HING
|
ALTOR BIOSCIENCE CORPORATION
|
|
Community Clinical Oncology Program Research Base
|
5U10CA037422-20
|
$1,483,085
|
$14,831
|
CURRAN, WALTER
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Bay Area Tumor Institute CCOP
|
2U10CA045461-18
|
$480,000
|
$4,800
|
FEUSNER, JAMES
|
BAY AREA TUMOR INSTITUTE
|
|
Tumor vaccination by modulation of inhibitory signaling in antigen-presenting cel
|
5R01CA116677-02
|
$232,676
|
$232,676
|
Chen, SiYi
|
BAYLOR COLLEGE OF MEDICINE
|
|
Repression by C SKI and Melanoma Progression
|
5R01CA084282-07
|
$264,568
|
$264,568
|
MEDRANO, ESTELA
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
1P30CA125123-01
|
$1,500,000
|
$45,000
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-01S1
|
$111,700
|
$3,351
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Enhancement of Dendritic Cells for Improved Immunotherapy
|
5R01CA120411-02
|
$258,529
|
$51,706
|
SPENCER, DAVID
|
BAYLOR COLLEGE OF MEDICINE
|
|
Antigen specificity, suppressive mechanisms and regulation of CD4+ regulatory T c
|
5R01CA116408-02
|
$258,529
|
$258,529
|
Wang, Rongfu
|
BAYLOR COLLEGE OF MEDICINE
|
|
Improving the Efficacy of Dendritic Cell Vaccines
|
5P01CA084512-06
|
$978,697
|
$782,958
|
Banchereau, Jacques
|
BAYLOR RESEARCH INSTITUTE
|
|
Subpopulations of Human Dendritic Cells
|
5R01CA078846-09
|
$292,811
|
$146,406
|
Banchereau, Jacques
|
BAYLOR RESEARCH INSTITUTE
|
|
Virginia Mason Community Clinical Oncology Program
|
3U10CA035192-24S1
|
$80,000
|
$800
|
Vuky, Jacqueline
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
Virginia Mason Community Clinical Oncology Program
|
5U10CA035192-24
|
$391,000
|
$3,910
|
Vuky, Jacqueline
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
Ras Peptide Aptamers
|
5R01CA108795-03
|
$320,225
|
$128,090
|
XU, C
|
BIOLOGICAL RESEARCH INSTITUTE
|
|
Regulation of apoptosis by PI 3-kinase/Akt signaling
|
5R01CA018689-31
|
$457,492
|
$45,749
|
COOPER, GEOFFREY
|
BOSTON UNIVERSITY
|
|
Ras Oncoprotein-Targeted Therapy for Cancer
|
3R01CA112102-03S1
|
$49,449
|
$24,725
|
Faller, Douglas
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Ras Oncoprotein-Targeted Therapy for Cancer
|
5R01CA112102-03
|
$302,435
|
$151,218
|
Faller, Douglas
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Case-Control Surveillance of Serious Illnesses and Drugs
|
5R01CA045762-18
|
$793,862
|
$39,693
|
Rosenberg, Lynn
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Genetic Variants in Pigmentation Genes and Skin Cancer Risk
|
1R03CA128080-01
|
$87,500
|
$28,875
|
HAN, JIALI
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Genetic Variants in Immunological Mediator Genes and Skin Cancer Risk
|
1R03CA132175-01
|
$86,936
|
$29,558
|
HAN, JIALI
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
SPORE in Skin Cancer
|
3P50CA093683-05S2
|
$512,285
|
$409,828
|
KUPPER, THOMAS
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Nitric Oxide Synthase Polymorphisms and Risk for Skin Cancer
|
1R03CA130055-01
|
$87,500
|
$28,875
|
QURESHI, ABRAR
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Function of ATF2 URE Binding Protein in Human Melanoma
|
2R01CA051995-16A1
|
$391,867
|
$391,867
|
RONAI, ZE'EV
|
BURNHAM INSTITUTE FOR MEDICAL RESEARCH
|
|
ATF2 in melanoma development and progression
|
5R01CA099961-05
|
$402,953
|
$402,953
|
RONAI, ZE'EV
|
BURNHAM INSTITUTE FOR MEDICAL RESEARCH
|
|
Novel Insights in the regulation of HIF1alpha Stability
|
5R01CA111515-04
|
$371,262
|
$148,505
|
RONAI, ZE'EV
|
BURNHAM INSTITUTE FOR MEDICAL RESEARCH
|
|
ATF2 in DNA damage response.
|
5R01CA117927-02
|
$447,626
|
$223,813
|
RONAI, ZE'EV
|
BURNHAM INSTITUTE FOR MEDICAL RESEARCH
|
|
CANCER CENTER SUPPORT GRANT
|
5P30CA030199-27
|
$3,387,817
|
$271,025
|
VUORI, KRISTIINA
|
BURNHAM INSTITUTE FOR MEDICAL RESEARCH
|
|
NanoSystems Biology Cancer Center
|
5U54CA119347-03
|
$3,507,584
|
$350,758
|
HEATH, JAMES
|
CALIFORNIA INSTITUTE OF TECHNOLOGY
|
|
CCOP Research Base, PCPT/PCPT LTFU, and SELECT Programs
|
2U10CA037429-22
|
$14,335,283
|
$143,353
|
Coltman, Charles
|
CANCER THERAPY AND RESEARCH CENTER
|
|
Carle Cancer Center Community Clinical Oncology Program
|
3U10CA035195-24S1
|
$120,000
|
$1,200
|
ROWLAND, KENDRITH
|
CARLE CLINIC ASSOCIATION, P C
|
|
Carle Cancer Center Community Clinical Oncology Program
|
5U10CA035195-24
|
$693,116
|
$6,931
|
ROWLAND, KENDRITH
|
CARLE CLINIC ASSOCIATION, P C
|
|
Design of Targeting Enhancement for Drug Delivery
|
5R21CA112436-02
|
$143,441
|
$71,721
|
DORMIDONTOVA, ELENA
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
2P30CA043703-18
|
$5,104,000
|
$51,040
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Modulating Base Excision Repair in Tumor Drug Resistance
|
5R01CA086357-08
|
$261,129
|
$86,173
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Cedar Rapids Oncology Project
|
5U10CA052352-18
|
$423,530
|
$4,235
|
WIESENFELD, MARTIN
|
CEDAR RAPIDS ONCOLOGY PROJECT
|
|
Discovery and Clinical Validation of Cancer Biomarkers Using Printed Glycan Array
|
1U01CA128526-01
|
$423,001
|
$105,750
|
HUFLEJT, MARGARET
|
CELLEXICON, INC.
|
|
ABCB5 P-Glycoprotein in Cancer Multidrug Resistance
|
5R01CA113796-02
|
$291,276
|
$291,276
|
Frank, Markus
|
CHILDREN'S HOSPITAL BOSTON
|
|
Cancer Biology in the Zebrafish
|
5R01CA103846-05
|
$341,771
|
$51,266
|
ZON, LEONARD
|
CHILDREN'S HOSPITAL BOSTON
|
|
ECM MATRIX, PROTEASE AND MELANOMA PROLIFERATION
|
5R01CA098469-05
|
$251,139
|
$251,139
|
DeClerck, Yves
|
CHILDREN'S HOSPITAL LOS ANGELES
|
|
Epigenetic Effect of the Microenvironment on Stem Cell Plasticity and Function
|
1R01CA121205-01A2
|
$298,619
|
$298,619
|
HENDRIX, MARY
|
CHILDREN'S MEMORIAL HOSPITAL (CHICAGO)
|
|
Endothelial Transdifferentiation of Invasive Tumor Cells
|
4R37CA059702-15
|
$401,734
|
$401,734
|
HENDRIX, MARY
|
CHILDREN'S MEMORIAL HOSPITAL (CHICAGO)
|
|
Gangliosides and the Biology of Human Neuroblastoma
|
5R01CA042361-16
|
$261,674
|
$13,084
|
LADISCH, STEPHAN
|
CHILDREN'S RESEARCH INSTITUTE
|
|
Delaware/Christiana Care CCOP
|
2U10CA045418-21
|
$835,003
|
$8,350
|
GRUBBS, STEPHEN
|
CHRISTIANA CARE HEALTH SERVICES, INC.
|
|
Delaware/Christiana Care CCOP
|
3U10CA045418-21S1
|
$119,011
|
$1,190
|
Grubbs, Stephen
|
CHRISTIANA CARE HEALTH SERVICES, INC.
|
|
CCNY/MSK Cancer Center Partnership
|
3U56CA096299-05S1
|
$192,500
|
$48,125
|
HUBBARD, KAREN
|
CITY COLLEGE OF NEW YORK
|
|
Inhibitors in Src Signaling for Antitumor Therapy
|
1R01CA115674-01A1
|
$288,990
|
$144,495
|
Jove, Richard
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA033572-24S1
|
$61,920
|
$619
|
KRONTIRIS, THEODORE
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA033572-24S2
|
$103,852
|
$1,039
|
KRONTIRIS, THEODORE
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
Total relevant funding to Melanoma for this search: $97,724,368
|